Human health microbiomics studies microbial communities across the body and their roles in metabolism, immunity, inflammation, disease risk, therapeutic response, and systems-level health.
Human health microbiomics examines how microbial communities influence biological function across the gut, skin, oral cavity, respiratory tract, reproductive system, and other body sites. These microbial ecosystems interact with host immunity, metabolism, epithelial barriers, inflammation, and disease-associated pathways.
At PanorOmics, human health is presented as a core microbiomics research area: a bridge between microbial ecology, host biology, chronic disease, immune regulation, biomarker discovery, precision health, and multi-omics interpretation.
Studying how gut microbial communities influence digestion, immunity, metabolism, inflammation, and systemic health.
Analyzing how microbes communicate with host cells, immune pathways, metabolic networks, and epithelial barriers.
Investigating microbial patterns associated with obesity, diabetes, cancer, inflammatory bowel disease, neurological disorders, and cardiovascular disease.
Identifying microbial signatures that support disease risk assessment, diagnosis, prognosis, treatment response, and precision health research.
Amplicon sequencing used to profile bacterial and archaeal community composition across human-associated microbiome samples.
Whole-community DNA sequencing used to identify microbial species, genes, pathways, and functional potential.
RNA-based microbiome profiling used to study active microbial gene expression and functional response.
Combines microbial community data with metabolite profiles to understand host–microbe biochemical interactions.
Computational approaches that support microbial classification, health-state prediction, biomarker discovery, and systems-level interpretation.
Profiles intestinal microbial communities involved in metabolism, immunity, inflammation, and gastrointestinal health.
Studies microbial communities in the mouth associated with oral health, inflammation, systemic disease, and microbial transmission.
Analyzes skin-associated microbes involved in barrier function, immune response, infection risk, and inflammatory skin disease.
Studies airway and lung microbial communities linked to infection, inflammation, asthma, COPD, and respiratory health.
Profiles microbial communities associated with reproductive health, pregnancy, inflammation, and disease risk.
Combines microbiome data with genomics, transcriptomics, proteomics, metabolomics, lipidomics, and clinical information.
Related microbiomic approaches such as environmental science, precision medicine, and infectious disease microbiomics are explored across the Microbiomics Research Center.
Culture-based microbiology established that microbes colonize the human body and influence infection, digestion, and health.
DNA-based methods expanded human microbiome research beyond culture-based detection toward community-level microbial analysis.
Large-scale efforts characterized microbial communities across human body sites and established reference frameworks for human microbiome research.
Human microbiome studies increasingly linked microbial community patterns with chronic disease, metabolism, immunity, and inflammation.
Integrated omics approaches connect microbial communities with host gene expression, metabolites, proteins, immune pathways, and clinical phenotypes.
Microbiome signatures increasingly support patient stratification, disease risk modeling, nutrition research, and precision health studies.
AI increasingly supports microbial pattern recognition, disease association discovery, host–microbiome modeling, and precision health research.
Continue exploring the Microbiomics Research Center.
Continue exploring the Microbiomics Research Center.
Continue exploring the Microbiomics Research Center.